ABCB10 and metabolic dysfunction-associated steatotic liver disease: We previously showed that an upregulation of the mitochondrial biliverdin exporter ABCB10 exacerbated non-alcoholic liver disease (NAFLD), by decreasing mitochondrial function and suppressing beneficial ROS-derived signals in hepatocytes [6].